Cargando…
PD-L1 expression and prognosis in definitive radiotherapy patients with neuroendocrine cervical carcinoma
BACKGROUND: Neuroendocrine carcinoma of the cervix (NECC) is more prone to lymphatic infiltration, lymph node involvement, local recurrence, and distant metastasis. Using concurrent chemoradiotherapy (CCRT) with or without adjuvant chemotherapy as the standard treatment for locally advanced NECCs an...
Autores principales: | Li, Huiling, Li, Xiuhua, Yang, Meichun, Su, Huiyan, Zhang, Jianqiu, Hu, Chunmiao, Sun, Yingming, Hu, Dan, Chen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431195/ https://www.ncbi.nlm.nih.gov/pubmed/37593242 |
Ejemplares similares
-
A model to guide the management and decision of re-planning during radiotherapy for cervical cancer
por: Zhang, Wei, et al.
Publicado: (2021) -
Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors
por: Fan, Yangwei, et al.
Publicado: (2016) -
Predictors of Distant Metastasis in Patients with Cervical Cancer Treated with Definitive Radiotherapy
por: Liu, Xiaoliang, et al.
Publicado: (2019) -
PD-L1, Mismatch Repair Protein, and NTRK Immunohistochemical Expression in Cervical Small Cell Neuroendocrine Carcinoma
por: Chen, Longyun, et al.
Publicado: (2021) -
PD‐L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer
por: Ji, Xiaoyu, et al.
Publicado: (2021)